NCT06729840View on ClinicalTrials.gov

Intralesional Treatment of Keloids

PHASE3RecruitingINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

May 2, 2025

Conditions

Scar, Hypertrophic

Interventions

DRUG

Injection

Vitamin D , botox , tramcinolone intralesionally injected in keloid

Trial Locations (1)

Unknown

RECRUITING

Sohag university hospital, Sohag

All Listed Sponsors

lead

Sohag University

OTHER